Targeted gene therapies: tools, applications, optimization
- 28 January 2012
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Biochemistry and Molecular Biology
- Vol. 47 (3) , 264-281
Abstract
Many devastating human diseases are caused by mutations in a single gene that prevent a somatic cell from carrying out its essential functions, or by genetic changes acquired as a result of infectious disease or in the course of cell transformation. Targeted gene therapies have emerged as potential strategies for treatment of such diseases. These therapies depend upon rare-cutting endonucleases to cleave at specific sites in or near disease genes. Targeted gene correction provides a template for homology-directed repair, enabling the cell’s own repair pathways to erase the mutation and replace it with the correct sequence. Targeted gene disruption ablates the disease gene, disabling its function. Gene targeting can also promote other kinds of genome engineering, including mutation, insertion, or gene deletion. Targeted gene therapies present significant advantages compared to approaches to gene therapy that depend upon delivery of stably expressing transgenes. Recent progress has been fueled by advances in nuclease discovery and design, and by new strategies that maximize efficiency of targeting and minimize off-target damage. Future progress will build on deeper mechanistic understanding of critical factors and pathways.Keywords
This publication has 189 references indexed in Scilit:
- Triplex technology in studies of DNA damage, DNA repair, and mutagenesisBiochimie, 2011
- Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point MutationsCell, 2011
- Creating Designed Zinc-Finger Nucleases with Minimal CytotoxicityJournal of Molecular Biology, 2011
- Reprogramming the pluripotent cell cycle: Restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cellsJournal of Cellular Physiology, 2010
- Directed Evolution of an Enhanced and Highly Efficient FokI Cleavage Domain for Zinc Finger NucleasesJournal of Molecular Biology, 2010
- Origin of Chromosomal Translocations in Lymphoid CancerCell, 2010
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA BreaksCell, 2010
- Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic RegionsCell, 2010
- Engineering Variants of the I-SceI Homing Endonuclease with Strand-specific and Site-specific DNA-nicking ActivityJournal of Molecular Biology, 2008
- Coevolution of a Homing Endonuclease and Its Host Target SequenceJournal of Molecular Biology, 2007